MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Northwest Biothrputcs Inc (OP:NWBO)

0.1524 +0.0035 (+2.35%)
Delayed Quote Updated: 3:59 PM EDT, Oct 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,537,883
Open 0.1425
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.1489
Today's Range 0.1421 - 0.1524
52wk Range 0.1411 - 0.3389
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioMedNewsBreaks — Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Advances Delivery-Focused Oncology Platform Amid Growing Interest in Drug-Delivery Technologies
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
How Advanced Drug Delivery Could Improve Existing Cancer Treatments
Via Investor Brand Network

Performance

YTD
-40.2%
-40.2%
1 Month
-10.5%
-10.5%
3 Month
-16.7%
-16.7%
6 Month
-25.0%
-25.0%
1 Year
-36.6%
-36.6%

More News

Read More
InvestorNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Targets CNS Drug Delivery Opportunity as Brain Therapeutics Innovation Accelerates
Via Investor Brand Network
Topics Intellectual Property
Stocks to Watch in May 2023: FOBI.V / FOBIF, NWBO, ENZC, GEVI
Via AB Newswire
Topics Artificial Intelligence
News headline image
How Advanced Drug Delivery Could Improve Existing Cancer Treatments
From BioMedWire
Via GlobeNewswire
News headline image
Biotech Healthcare: CSDX, NWBO, BSEM, RDGL, NRXBF Emerging Stocks to Watch
Via AB Newswire
News headline image
CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities
From BioMedWire
Via GlobeNewswire
12 OTC Stocks to Watch: Clean Vision Corporation (OTCQB: CLNV), NaturalShrimp Inc (OTCQB: SHMP), Northwest Biotherapeutics, Inc. (OTCQB: NWBO), and More
Via AB Newswire
Topics Intellectual Property
Stock Market Surges “Milestones Reached”: SWISF / SKUR.C, NWBO, ENZC, ABML
Via AB Newswire
News headline image
Cohen Milstein Files Lawsuit on Behalf of Northwest Biotherapeutics Against Major Market Makers for Market Manipulation
Via ACN Newswire
Topics Law Enforcement Lawsuit
News headline image
NWBO Stock Alert: Northwest Bio Slams Citadel Securities in New Lawsuit ↗
Via InvestorPlace
News headline image
A Quick Look At The OTC Markets' Most-Active Securities In August - Here's What You Need to Know ↗
Via Benzinga
News headline image
These 2 Under-The-Radar Stocks Traded More Than $1B Each Last Month ↗
Via Benzinga
News headline image
Mortgage Financiers & Crypto Securities Reclaim Their Spots As Most Actively Traded Securities On OTC Markets In June ↗
Via Benzinga
News headline image
The OTC Markets' Most-Active Securities Embrace International Operators As Volatility Envelops Markets In May ↗
Via Benzinga
News headline image
If You Invested $1000 In Northwest Biotherapeutics 5 Years Ago, Here's How Much You Would Have Today ↗
Via Benzinga
News headline image
Northwest Biotherapeutics, Inc. (OTC:NWBO) Investor Notice: Investigation over Potential Wrongdoing ↗
Via SBWire

Frequently Asked Questions

Is Northwest Biothrputcs Inc publicly traded?
Yes, Northwest Biothrputcs Inc is publicly traded.
What exchange does Northwest Biothrputcs Inc trade on?
Northwest Biothrputcs Inc trades on the OTC Traded
What is the ticker symbol for Northwest Biothrputcs Inc?
The ticker symbol for Northwest Biothrputcs Inc is NWBO on the OTC Traded
What is the current price of Northwest Biothrputcs Inc?
The current price of Northwest Biothrputcs Inc is 0.1524
When was Northwest Biothrputcs Inc last traded?
The last trade of Northwest Biothrputcs Inc was at 10/01/26 03:59 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story